Hims & Hers Health ( (HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Hims & Hers Health’s stock has experienced unusual movements due to a Hold rating from both Morgan Stanley and Truist Financial. While the company’s technological innovations like MedMatch and custom EHR are seen as promising, concerns about the focus on GLP-1 and ambitious growth targets contribute to short-term volatility. Additionally, increased insider selling adds to the cautious outlook. Morgan Stanley and Truist Financial have set price targets at $60.00 and $39.00, respectively.
More about Hims & Hers Health
YTD Price Performance: 60.67%
Average Trading Volume: 19,494,233
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $9B
For further insights into HIMS stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.